Quick Answer ACADIA PHARMACEUTICALS INC reported Total Revenue of $1.07 billion for fiscal year 2025. ACADIA PHARMACEUTICALS INC Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $1.07B +11.9% 2024 $957.80M +31.8% 2023 $726.44M +40.4% 2022 $517.24M +6.8% 2021 $484.14M +9.6% 2020 $441.75M +30.3% 2019 $339.08M +51.5% 2018 $223.81M +79.2% 2017 $124.90M … Read more
Quick Answer ACADIA PHARMACEUTICALS INC reported Total Revenue of $1.07 billion for fiscal year 2025. ACADIA PHARMACEUTICALS INC — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $1.07B+11.9% $957.80M+31.8% $726.44M+40.4% $517.24M+6.8% $484.14M+9.6% $441.75M+30.3% Revenue (ASC 606) $1.07B+11.9% $957.80M+31.8% $726.44M+40.4% $517.24M+6.8% $484.14M+9.6% $441.75M+30.3% Net Income $391.00M+72.7% $226.45M+469.5% -$61.29M+71.6% -$215.97M-28.7% -$167.87M+40.4% -$281.58M-19.7% … Read more
Quick Answer Arcosa, Inc. reported Shares Outstanding of 49.00 million shares for fiscal year 2025. Arcosa, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 49.00M +0.4% 2024 48.80M +0.4% 2023 48.60M +0.4% 2022 48.40M +0.2% 2021 48.30M +0.2% 2020 48.20M -0.2% 2019 48.30M -1.0% 2018 48.80M — 2017 0 — … Read more
Quick Answer Arcosa, Inc. reported Gross Profit of $647.20 million for fiscal year 2025. Arcosa, Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $647.20M +25.6% 2024 $515.20M +16.1% 2023 $443.80M — Quarterly Gross Profit Quarter Ending Gross Profit YoY QoQ September 30, 2025 $191.90M +40.4% +15.5% June 30, 2025 $166.10M … Read more
Quick Answer Arcosa, Inc. reported Operating Income of $341.90 million for fiscal year 2025. Arcosa, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $341.90M +73.0% 2024 $197.60M -9.1% 2023 $217.30M -37.7% 2022 $349.00M +225.3% 2021 $107.30M -29.3% 2020 $151.80M -0.7% 2019 $152.90M +61.1% 2018 $94.90M -27.9% 2017 $131.70M -34.4% 2016 … Read more
Quick Answer Arcosa, Inc. reported Cash and Equivalents of $214.60 million for fiscal year 2025. Arcosa, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $214.60M +14.6% 2024 $187.30M +78.7% 2023 $104.80M -34.7% 2022 $160.40M +120.0% 2021 $72.90M -23.9% 2020 $95.80M -60.1% 2019 $240.40M +141.9% 2018 $99.40M +1361.8% 2017 … Read more
Quick Answer Arcosa, Inc. reported Stockholders Equity of $2.64 billion for fiscal year 2025. Arcosa, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $2.64B +8.8% 2024 $2.43B +4.1% 2023 $2.33B +6.8% 2022 $2.18B +11.8% 2021 $1.95B +3.2% 2020 $1.89B +5.7% 2019 $1.79B +6.3% 2018 $1.68B +19.6% 2017 $1.41B +4.9% 2016 … Read more
Quick Answer Arcosa, Inc. reported Total Assets of $4.99 billion for fiscal year 2025. Arcosa, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $4.99B +1.4% 2024 $4.92B +37.4% 2023 $3.58B +7.1% 2022 $3.34B +4.8% 2021 $3.19B +20.5% 2020 $2.65B +14.9% 2019 $2.30B +6.0% 2018 $2.17B +35.6% 2017 $1.60B +5.0% 2016 … Read more
Quick Answer Arcosa, Inc. reported Diluted EPS of $4.24 per share for fiscal year 2025. Arcosa, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $4.24 +122.0% 2024 $1.91 -41.4% 2023 $3.26 -35.4% 2022 $5.05 +255.6% 2021 $1.42 -34.9% 2020 $2.18 -6.0% 2019 $2.32 +50.6% 2018 $1.54 -16.3% 2017 $1.84 -27.0% … Read more
Quick Answer Arcosa, Inc. reported Net Income of $208.40 million for fiscal year 2025. Arcosa, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $208.40M +122.4% 2024 $93.70M -41.1% 2023 $159.20M -35.2% 2022 $245.80M +253.2% 2021 $69.60M -34.7% 2020 $106.60M -5.9% 2019 $113.30M +49.7% 2018 $75.70M -15.6% 2017 $89.70M -27.1% 2016 … Read more